Braun J, Baraliakos X, Hermann K-GA, et al. Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo-controlled GO-RAISE study. Ann Rheum Dis 2012;71:878–84. In table 3, the interquartile range for the median change at week 14 in the golimumab 50 mg group currently reads as 10.8, −0.3 and should be −10.8, −0.3.